Consensus InventisBio Co., Limited

Equities

688382

CNE100005Q22

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-08 pm EDT			5-day change	1st Jan Change
9.93 ^CNY	+1.43%		+1.74%	-34.41%

Apr. 29	InventisBio Co., Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 11	Sino Biopharmaceutical Presents Cancer Drug's Phase-II Clinical Trial Results at AACR 2024	MT

Evolution of the average Target Price on InventisBio Co., Limited

Price target over the last 5 years

History of analyst recommendation changes

3393c60a41eb857b9dcf.MxFrRA1zeIaMKByOnvFbh7JU3xV54H2QNqF5m8BtwvM.QCUHPFcbNMnaY2jA9Kgv3cs2tVERpBnGbPAaypcjqsUKZicmREsK6d9wVQ~e2784bfcfbc7b5b7186523fe8c4ff46a

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

9.93 CNY

Average target price

18.5 CNY

Spread / Average Target

+86.30%

High Price Target

20 CNY

Spread / Highest target

+101.41%

Low Price Target

17 CNY

Spread / Lowest Target

+71.20%

Consensus detail

Consensus revision (last 18 months)

Ratings for InventisBio Co., Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar